SAM #36C25626Q0790

Sole Source BPA for Ortho Vision Analyzer, Reagents, Consumables, and Service Support at Central Arkansas Veterans Health Care System

This notice announces the Department of Veterans Affairs' intent to award a sole source Blanket Purchase Agreement to Quidelortho Sales Company, LLC for Ortho Vision Analyzer equipment, reagents, consumables, and service support at the Central Arkansas Veterans Health Care System. - Sole source procurement for Ortho Vision Analyzer, reagents, consumables, and service support - Only Quidelortho Sales Company, LLC is authorized to supply these items - All products must be compatible with government-owned Ortho workstations immunohematology analyzers - Products requested include: - Ortho Vision Analyzer (automated immunohematology analyzer) - Multiple types of MTS gel cards (A/B/D MONO & REV GRP, AB MONO GROUP, ANTI-A,B MONO GEL CD, ANTI-IGG CARD) - Reagents (0.8% AFFIRMAGEN, 0.8% RESOLVE A, 0.8% RESOLVE C, 0.8% SURG, MTS ROUND DIL2, MTS ROUND DIL2+, ORTHO 7% BSA) - Consumables (OV SINGLE USE DILUTION TRAY, OV SINGLE USE EVAPORATION CAPS, MTS-ID Pipette Tips-Racked, Buffered Gel Cards) - Quality control items (Ortho Daily QC Simulated Whole Blood Control, Ortho Daily QC Kit) - Service support includes maintenance and technical support for Ortho Vision Analyzer and related systems - Brand name only requirement; no substitutes accepted - NAICS code: 325413 (In-Vitro Diagnostic Substance Manufacturing) - Place of performance: Central Arkansas Veterans Health Care System - Contracting office: Network Contracting Office 16, Houston, TX - Period of performance: Firm-Fixed-Price BPA, not to exceed five years

Description

SPECIAL NOTICE NOTICE OF INTENT TO AWARD SOLE SOURCE

I. The Network Contracting Office (NCO) 16, located at Galleria Financial Center, 5075 Westheimer Rd, Ste 750, Houston, TX 77056 in support of Central Arkansas Veterans Health Care System (CAVHCS), intends to solicit and award Sole Source, Firm-Fixed-Price, Blanket Purchase Agreement (BPA) with one Large Business source, Quidelortho Sales Company, LLC.

Quidelortho Sales Company, LLC 9975 Summers Ridge Rd San Diego, CA 92121-2997

CAVHCS has a requirement for brand name ortho vision analyzer to include reagents, service support and consumables that are already compatible with the government owned ortho workstations immunohematology analyzer. To include current inventory inclusive of cartridges, reagents and controls. Ortho has a six-well gel card that only works with government owned ortho workstations currently in use at the CAVHCS.

Quidelortho Sales Company, LLC., is currently the only authorized provider for the analyzers, reagents, controls, consumables and service support for the ortho vision analyzer, ortho workstations and IDS-MATS Gel Card systems.

The instrument is designed to automate in vitro immunohematology testing of human blood utilizing ID-Micro Typing System (ID-MTS ) gel card technology. The ortho vision analyzer automates test processing functions including liquid pipetting, reagent handling, incubation, centrifugation, reaction grading and interpretation, and data management requirements using cards and digital image processing.

Consumable and reagents include but not limited to:

MTS A/B/D MONO & REV GRP 5X20, 100 Cards/PG MTS A/B/D/A/B/D MONO GRP 5X20, 100 Cards/PG MTS AB MONO GROUP 5X20, 100 Cards/PG MTS ANTI-A,B MONO GEL CD 1X20, 20 Cards/PG MTS ANTI-IGG CARD 5X20, 100 Cards/PG 0.8% AFFIRMAGEN 2X10ML 0.8% RESOLVE A 11X3ML 0.8% RESOLVE C 22X3ML 0.8% SURG 3X10ML MTS ROUND DIL2 100ML/5BTLS MTS ROUND DIL2+ 100ML/5BTLS ORTHO 7% BSA OV SINGLE USE DILUTION TRAY OV SINGLE USE EVAPORATION CAPS 250 Ortho Daily QC Simulated Whole Blood Control MTS-ID Pipette Tips-Racked 12X96 Ortho Daily QC Kit Buffered Gel Cards

II. The North American Industry Classification (NAICS) code for this acquisition is 325413, In-Vitro Diagnostic Substance Manufacturing. Size Standard 1250.

III. This procurement is being conducted under General Services Acquisition Regulation (GSAR) subpart 538.7104-3(b)(ii)-Soliciting from a single source. IV. The anticipated award date is October 1, 2026. The Government intends to award a Firm-Fixed-Price Blanket Purchase Agreement (BPA). Period of performance will be the awarded BPA with option periods not exceeding five (5) years or sixty (60) months.

V. Please note that this is not a request for competitive quotes and is being posted for informational purposes only. The government does not anticipate receiving responses to this notice. However, interested parties who disagree with this action may submit a letter of interest that demonstrates your firm s technical capability to provide brand name ortho vision analyzer, reagents, maintenance and consumables. The contractor shall communicate its technical capability to provide compatible consumables, products and service support that will not duplicate the government cost. The government reserves the right to verify any request for additional documentation submitted.

VI. Interested parties shall identify their interests, provide information mentioned in section V of this document and capability to meet the government requirements and respond to this notice within fifteen (15) calendar days of the publication of this notice. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government.

Interested parties may identify their interest solely via email to Contracting Officer, Anthony Marion, Anthony.marion2@va.gov no later than May 28, 2026, 10:00am Central Standard Time (CST). When responding to this announcement, respondents should include 36C25626Q0790 Notice of Intent" in the subject line.

Questions or comments to this Notice of Intent to award Sole Source needs to be directed to anthony.marion2@va.gov no later than May 20, 2026, 10:00am Central Standard Time (CST).

VII. Late responses may not be accepted. No telephone inquiries will be accepted nor will phone calls be returned. Only emailed responses will be considered. The information received will be utilized solely for determining whether to conduct competitive procurement. A determination not to compete this proposed acquisition based upon responses to this notice is at the sole discretion of the Government.

View original listing